DIA 2018 Global Annual Meeting

The biopharma sector is under pressure to develop innovative and targeted new medicines that demonstrate therapeutic value to patients in need. The current R&D model is not sustainable and clinical development lacks the digital technology infrastructure and integration to leverage the wealth of information available to innovate in patient care. Join Deloitte as we discuss the strategies, technology, and partnerships necessary to build a scalable, sustainable digital R&D footprint. Learn how digital technologies can transform clinical development by increasing the types, amount, and quality of data collected in trials; generate valuable insights from that data; enhance the patient and investigator experience; and improve clinical trial productivity.